Page last updated: 2024-11-04

sulfadiazine and Burkholderia pseudomallei Infection

sulfadiazine has been researched along with Burkholderia pseudomallei Infection in 3 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MAEGRAITH, BG1
LEITHEAD, CS1
Cooper, EB1
Eickhoff, TC1
Bennett, JV1
Hayes, PS1
Feeley, J1

Other Studies

3 other studies available for sulfadiazine and Burkholderia pseudomallei Infection

ArticleYear
MELIOIDOSIS: A CASE-REPORT.
    Lancet (London, England), 1964, Apr-18, Volume: 1, Issue:7338

    Topics: Anti-Bacterial Agents; Chloramphenicol; Diagnosis, Differential; Humans; Iron; Liver Function Tests;

1964
Melioidosis.
    JAMA, 1967, May-08, Volume: 200, Issue:6

    Topics: Ampicillin; Cephalosporins; Chloramphenicol; Colistin; Humans; Kanamycin; Melioidosis; Novobiocin; P

1967
Pseudomonas pseudomallei: susceptibility to chemotherapeutic agents.
    The Journal of infectious diseases, 1970, Volume: 121, Issue:2

    Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Dicloxacillin; Drug Antagonism; Drug Synergism;

1970